279
Participants
Start Date
December 31, 1992
Primary Completion Date
March 31, 1995
Study Completion Date
March 31, 1995
Ganciclovir
intravenous ganciclovir induction at 5 mg/kg twice daily for 2 weeks followed by maintenance at 10 mg/kg/day
Foscarnet
intravenous foscarnet induction at 90 mg/kg twice daily for 2 weeks, followed by maintenance therapy at 120 mg/kg/day
National Eye Institute (NEI)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Johns Hopkins University
OTHER
University of Wisconsin, Madison
OTHER
Baylor College of Medicine
OTHER
Tulane University School of Medicine
OTHER
Icahn School of Medicine at Mount Sinai
OTHER
New York Presbyterian Hospital
OTHER
New York University
OTHER
Northwestern University
OTHER
University of California, Los Angeles
OTHER
University of California, San Francisco
OTHER
University of California, San Diego
OTHER
University of Miami
OTHER
University of North Carolina, Chapel Hill
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Johns Hopkins Bloomberg School of Public Health
OTHER